tradingkey.logo


tradingkey.logo


Kestra Medical Technologies Ltd

KMTS
19.460USD
-0.220-1.12%
終倀 03/27, 16:00ET15分遅れの株䟡
963.93M時䟡総額
損倱額盎近12ヶ月PER


Kestra Medical Technologies Ltd

19.460
-0.220-1.12%

詳现情報 Kestra Medical Technologies Ltd 䌁業名

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Kestra Medical Technologies Ltdの䌁業情報


䌁業コヌドKMTS
䌚瀟名Kestra Medical Technologies Ltd
䞊堎日Mar 06, 2025
最高経営責任者「CEO」Webster (Brian Daniel)
埓業員数330
蚌刞皮類Ordinary Share
決算期末Mar 06
本瀟所圚地3933 Lake Washington Blvd Ne
郜垂KIRKLAND
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号98033
電話番号14252798002
りェブサむト
䌁業コヌドKMTS
䞊堎日Mar 06, 2025
最高経営責任者「CEO」Webster (Brian Daniel)

Kestra Medical Technologies Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
249.34K
-6.02%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
94.42K
-11.12%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
14.84K
-148.67%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jeffrey Schwartz
Mr. Jeffrey Schwartz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Toby AuWerter
Mr. Toby AuWerter
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
249.34K
-6.02%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
94.42K
-11.12%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
14.84K
-148.67%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Bain Capital Private Equity, LP
43.12%
Fidelity Management & Research Company LLC
8.65%
T. Rowe Price Associates, Inc.
7.43%
Andera Partners S.A.S.
4.35%
Endeavour Medtech Growth II LP
4.20%
他の
32.25%
株䞻統蚈
株䞻統蚈
比率
Bain Capital Private Equity, LP
43.12%
Fidelity Management & Research Company LLC
8.65%
T. Rowe Price Associates, Inc.
7.43%
Andera Partners S.A.S.
4.35%
Endeavour Medtech Growth II LP
4.20%
他の
32.25%
皮類
株䞻統蚈
比率
Private Equity
47.96%
Investment Advisor
29.66%
Investment Advisor/Hedge Fund
15.83%
Corporation
4.20%
Venture Capital
2.35%
Hedge Fund
2.01%
Individual Investor
0.88%
Research Firm
0.29%
Sovereign Wealth Fund
0.14%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
173
50.44M
86.44%
+964.21K
2025Q3
138
48.47M
94.21%
+1.86M
2025Q2
93
49.39M
96.22%
+48.70M
2025Q1
74
47.97M
93.41%
+47.97M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Bain Capital Private Equity, LP
27.02M
46.31%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.35M
7.45%
+1.51M
+53.18%
Sep 30, 2025
T. Rowe Price Associates, Inc.
1.82M
3.11%
+825.66K
+83.35%
Sep 30, 2025
Endeavour Medtech Growth II LP
2.65M
4.54%
+2.65M
--
Mar 31, 2025
Ally Bridge Group (HK) Limited
2.28M
3.91%
--
--
Sep 30, 2025
Brown Advisory
1.26M
2.16%
+679.34K
+117.12%
Sep 30, 2025
AllianceBernstein L.P.
1.49M
2.56%
+179.88K
+13.71%
Sep 30, 2025
Omega Fund Management, LLC
1.65M
2.82%
--
--
Sep 30, 2025
Eventide Asset Management, LLC
1.20M
2.06%
+143.81K
+13.56%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Global X HealthTech ETF
0.43%
Goldman Sachs Innovate Equity ETF
0.13%
Fidelity Blue Chip Growth ETF
0.06%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Global X Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Morningstar Small-Cap ETF
0.01%
詳现を芋る
Global X HealthTech ETF
比率0.43%
Goldman Sachs Innovate Equity ETF
比率0.13%
Fidelity Blue Chip Growth ETF
比率0.06%
JPMorgan BetaBuilders US Small Cap Equity ETF
比率0.04%
iShares Russell 2000 Growth ETF
比率0.02%
Fidelity Nasdaq Composite Index ETF
比率0.01%
Global X Russell 2000 ETF
比率0.01%
Schwab U.S. Small-Cap ETF
比率0.01%
iShares Russell 2000 ETF
比率0.01%
iShares Morningstar Small-Cap ETF
比率0.01%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™